Works matching AU Gómez ‐ Cañas, María

Results: 11
    1

    Δ<sup>9</sup> -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB<sub>1</sub> receptors.

    Published in:
    2020
    By:
    • Palomares, Belén;
    • Garrido‐Rodriguez, Martín;
    • Gonzalo‐Consuegra, Claudia;
    • Gómez‐Cañas, María;
    • Saen‐oon, Suwipa;
    • Soliva, Robert;
    • Collado, Juan A.;
    • Fernández‐Ruiz, Javier;
    • Morello, Gaetano;
    • Calzado, Marco A.;
    • Appendino, Giovanni;
    • Muñoz, Eduardo;
    • Garrido-Rodriguez, Martín;
    • Gonzalo-Consuegra, Claudia;
    • Gómez-Cañas, María;
    • Saen-Oon, Suwipa;
    • Fernández-Ruiz, Javier
    Publication type:
    journal article
    2

    VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB<sub>2</sub> receptor-dependent pathways.

    Published in:
    2018
    By:
    • del Rio, Carmen;
    • Cantarero, Irene;
    • Palomares, Belén;
    • Gómez‐Cañas, María;
    • Fernández‐Ruiz, Javier;
    • Pavicic, Carolina;
    • García‐Martín, Adela;
    • Luz Bellido, Maria;
    • Ortega‐Castro, Rafaela;
    • Pérez‐Sánchez, Carlos;
    • López‐Pedrera, Chary;
    • Appendino, Giovanni;
    • Calzado, Marco A.;
    • Muñoz, Eduardo;
    • Gómez-Cañas, María;
    • Fernández-Ruiz, Javier;
    • García-Martín, Adela;
    • Ortega-Castro, Rafaela;
    • Pérez-Sánchez, Carlos;
    • López-Pedrera, Chary
    Publication type:
    journal article
    3

    Prospects for cannabinoid therapies in basal ganglia disorders.

    Published in:
    2011
    By:
    • Fernández-Ruiz, Javier;
    • Moreno-Martet, Miguel;
    • Rodríguez-Cueto, Carmen;
    • Palomo-Garo, Cristina;
    • Gómez-Cañas, María;
    • Valdeolivas, Sara;
    • Guaza, Carmen;
    • Romero, Julián;
    • Guzmán, Manuel;
    • Mechoulam, Raphael;
    • Ramos, José A;
    • Fernández-Ruiz, Javier;
    • Rodríguez-Cueto, Carmen;
    • Gómez-Cañas, María;
    • Romero, Julián;
    • Guzmán, Manuel;
    • Ramos, José A
    Publication type:
    journal article
    4

    Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.

    Published in:
    Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01284
    By:
    • Götz, Marcus R.;
    • Collado, Juan A.;
    • Fernández-Ruiz, Javier;
    • Fiebich, Bernd L.;
    • García-Toscano, Laura;
    • Gómez-Cañas, María;
    • Koch, Oskar;
    • Leha, Andreas;
    • Muñoz, Eduardo;
    • Navarrete, Carmen;
    • Pazos, Maria R.;
    • Holzgrabe, Ulrike
    Publication type:
    Article
    5

    The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.

    Published in:
    Scientific Reports, 2016, p. 21703, doi. 10.1038/srep21703
    By:
    • del Río, Carmen;
    • Navarrete, Carmen;
    • Collado, Juan A.;
    • Bellido, M. Luz;
    • Gómez-Cañas, María;
    • Pazos, M. Ruth;
    • Fernández-Ruiz, Javier;
    • Pollastro, Federica;
    • Appendino, Giovanni;
    • Calzado, Marco A.;
    • Cantarero, Irene;
    • Muñoz, Eduardo
    Publication type:
    Article
    6
    7

    Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties.

    Published in:
    Archiv der Pharmazie, 2013, v. 346, n. 3, p. 171, doi. 10.1002/ardp.201200392
    By:
    • Fernández ‐ Fernández, Cristina;
    • Decara, Juan;
    • Bermúdez ‐ Silva, Francisco J.;
    • Sánchez, Eva;
    • Morales, Paula;
    • Gómez ‐ Cañas, María;
    • Gómez ‐ Ruíz, María;
    • Callado, Luis F.;
    • Goya, Pilar;
    • Rodríguez de Fonseca, Fernando;
    • Martín, M. Isabel;
    • Fernández ‐ Ruíz, Javier;
    • Meana, J. Javier;
    • Jagerovic, Nadine
    Publication type:
    Article
    8

    Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

    Published in:
    Molecules, 2021, v. 26, n. 24, p. 7643, doi. 10.3390/molecules26247643
    By:
    • Burgaz, Sonia;
    • García, Concepción;
    • Gonzalo-Consuegra, Claudia;
    • Gómez-Almería, Marta;
    • Ruiz-Pino, Francisco;
    • Unciti, Juan Diego;
    • Gómez-Cañas, María;
    • Alcalde, Juan;
    • Morales, Paula;
    • Jagerovic, Nadine;
    • Rodríguez-Cueto, Carmen;
    • de Lago, Eva;
    • Muñoz, Eduardo;
    • Fernández-Ruiz, Javier
    Publication type:
    Article
    9
    10

    A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.

    Published in:
    Journal of NeuroImmune Pharmacology, 2012, v. 7, n. 4, p. 1002, doi. 10.1007/s11481-012-9399-3
    By:
    • Granja, Aitor;
    • Carrillo-Salinas, Francisco;
    • Pagani, Alberto;
    • Gómez-Cañas, María;
    • Negri, Roberto;
    • Navarrete, Carmen;
    • Mecha, Miriam;
    • Mestre, Leyre;
    • Fiebich, Bend;
    • Cantarero, Irene;
    • Calzado, Marco;
    • Bellido, Maria;
    • Fernandez-Ruiz, Javier;
    • Appendino, Giovanni;
    • Guaza, Carmen;
    • Muñoz, Eduardo
    Publication type:
    Article
    11

    Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.

    Published in:
    2018
    By:
    • García, Concepción;
    • Gómez-Cañas, María;
    • Burgaz, Sonia;
    • Palomares, Belén;
    • Gómez-Gálvez, Yolanda;
    • Palomo-Garo, Cristina;
    • Campo, Sara;
    • Ferrer-Hernández, Joel;
    • Pavicic, Carolina;
    • Navarrete, Carmen;
    • Luz Bellido, M.;
    • García-Arencibia, Moisés;
    • Ruth Pazos, M.;
    • Muñoz, Eduardo;
    • Fernández-Ruiz, Javier
    Publication type:
    journal article